SSI Diagnostica Group is a global leader in infectious disease diagnostics, bringing together three companies - SSI Diagnostica, Techlab, and CTK Biotech – to support better treatment outcomes for patients worldwide. Our expertise spans three areas: gastric, respiratory, and bloodborne diseases. With 100+ years of scientific experience, we collaborate closely with the clinical community in: Disease Prevention & Outbreak Control: We partner with the vaccine industry, supplying them with high-quality antisera for life-saving vaccine development and quality control - helping to prevent and contain diseases globally. Disease Monitoring: Until 2016, where SSI Diagnostica was bought by Adelis Equity, SSI Diagnostica was part of Statens Serum Institut, which was founded in 1902 and is renowned globally for its very solid research. We are proud of this heritage and believe that it is part of our DNA to share knowledge where it makes a difference. Therefore, we continue contributing to monitoring efforts in case of disease outbreaks. Disease Diagnostics: We develop, manufacture, and sell state-of-the-art IVD diagnostic kits and consumables (including culture media, lateral flow tests, EIA & ELISA platforms) that deliver fast and reliable results trusted by clinicians worldwide. With production facilities in San Diego, Virginia, Beijing, and Hillerød (HQ), and with an extensive global distribution network, SSI Diagnostica Group has a reliable delivery of products globally. By bringing these companies together in the SSI Diagnostica Group, we have created a global IVD powerhouse that offers strong end-to-end services in clinical diagnostics. Our mission is simple: to support better treatment outcomes for patients globally. SSI Diagnostica Group holds various certifications across sites. SSI Diagnostica is ISO 13485 certified, with other sites holding ISO 14001 & MDSAP. The group is actively working towards IVDR for all sites, with certain sites already being certified.